Results of a trial of combined propamidine isethionate and neomycin therapy for acanthamoeba keratitis

Ophthalmology

Volumn 106, Issue 5, 1999, Pages 952-957

  Hargrave, Sylvia L ^a,b   McCulley, James P ^a   Husseini, Ziad ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRAMICIDIN; NEOMYCIN; NEOTRICIN; POLYMYXIN B; PROPAMIDINE ISETHIONATE;

ACANTHAMOEBA KERATITIS; ADULT; ARTICLE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; ERADICATION THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033504307     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)00515-1     Document Type: Article

References (31)

1. Moore MB, McCulley JP, Luckenbach M, et al. Acanthamoeba keratitis associated with soft contact lenses. Am J Ophthalmol 1985;100:396-403.
2. Silvany RE, Dougherty JM, McCulley JP, et al. The effect of currently available contact lens disinfection systems on Acanthamoeba castellanii and Acanthamoeba polyphaga. Ophthalmology 1990;97:286-90.
3. Silvany RE, Dougherty JM, McCulley JP. Effect of contact lens preservatives on Acanthamoeba. Ophthalmology 1991; 98:854-7.
4. Ubelaker JE, Moore MB, Martin JH, et al. In vitro intercellular adherence of Acanthamoeba castellanii: a scanning and transmission electron microscopy study. Cornea 1991;10:299-304.
5. Abbot RL, Elander TR. Acanthamoeba keratitis. In: Tasman W, ed; Jaeger EA, assoc ed. Duane's Clinical Ophthalmology, rev. ed. Philadelphia: Lippincott-Raven, 1997; V. 4, Chap. 18A.
6. van Klink F, Alizadeh H, Stewart GL, et al. Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis. Curr Eye Res 1992;11:1207-20.
7. Martinez AJ, Janitschke K. Acanthamoeba, an opportunistic microorganism: a review. Infection 1985;13:251-6.
8. Visvesvara GS. Free-living pathogenic amoebae. In: Lennette EH, editor-in-chief; Balows A, Hausler WJ Jr, Truant JP, eds. Manual of Clinical Microbiology, 3rd ed. Washington, DC: American Society for Microbiology, 1980.
9. Samples JR, Binder PS, Luibel FJ, et al. Acanthamoeba keratitis possibly acquired from a hot tub. Arch Ophthalmol 1984;102:707-10.
10. Jones DB, Visvesvara GS, Robinson NM. Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol Soc U K 1975; 95:221-32.
11. Visvesvara GS. Classification of Acanthamoeba. Rev Infect Dis 1991;13 (Suppl 5):S369-72.
12. Bacon AS, Frazer DG, Dart JKG, et al. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye 1993;7:719-25.
13. Cohen EJ, Buchanan HW, Laughrea PA, et al. Diagnosis and management of Acanthamoeba keratitis. Am J Ophthalmol 1985;100:389-95.
14. Moore MB, McCulley JP, Newton C, et al. Acanthamoeba keratitis. A growing problem in soft and hard contact lens wearers. Ophthalmology 1987;94:1654-61.
15. Wilhelmus KR, Osato MS, Font RL, et al. Rapid diagnosis of Acanthamoeba keratitis using calcofluor white. Arch Ophthalmol 1986;104:1309-12.
16. He YG, McCulley JP, Alizadeh H, et al. A pig model of Acanthamoeba keratitis: transmission via contaminated contact lenses. Invest Ophthalmol Vis Sci 1992;33: 126-33.
17. Florakis GJ, Folberg R, Krachmer JH, et al. Elevated corneal epithelial lines in Acanthamoeba keratitis. Arch Ophthalmol 1988;106:1202-6.
18. Auran JD, Starr MB, Jakobiec FA. Acanthamoeba keratitis. A review of the literature. Cornea 1987;6:2-26.
19. Mannis MJ, Tamaru R, Roth AM, et al. Acanthamoeba sclerokeratitis. Determining diagnostic criteria. Arch Ophthalmol 1986;104:1313-7.
20. Ma P, Willaert E, Juechter KB, Stevens AR. A case of keratitis due to Acanthamoeba in New York, New York, and features of 10 cases. J Infect Dis 1981;143:662-7.
21. Pfister DR, Cameron JD, Krachmer JH, Holland EJ. Confocal microscopy findings of Acanthamoeba keratitis. Am J Ophthalmol 1996;121:119-28.
22. Blackman HJ, Rao NA, Lemp MA, Visvesvara GS. Acanthamoeba keratitis successfully treated with penetrating keratoplasty: suggested immunogenetic mechanisms of action. Cornea 1984;3:125-30.
23. Osato MS, Robinson NM, Wilhelmus KR, Jones DB. In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba. Rev Infect Dis 1991;13 (Suppl 5): S431-5.
24. Larkin DFP, Kilvington S, Dart JKG. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992;99:185-91.
25. Hay J, Kirkness CM, Seal DV, Wright P. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye 1994;8:555-63.
26. Kaufman HE, Barron BA, McDonald MB. The Cornea, 2nd ed. Boston: Butterworth-Heinemann, 1996;338-43.
27. Elder MJ, Kilvington S, Dart JKG. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994;35:1059-64.
28. Bacon AS, Dart JKG, Ficker LA, et al. Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology 1993;100:1238-43.
29. Stern GA, Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology 1991;98:847-53.
30. Cavanagh HD, Petroll WM, Alizadeh H, et al. Clinical and diagnostic use of in vivo confocal microscopy in patients with corneal disease. Ophthalmology 1993;100:1444-54.
31. Chew SJ, Beuerman RW, Assouline M, et al. Early diagnosis of infectious keratitis with in vivo real time confocal microscopy. CLAO J 1992;18:197-201.